Read this company snapshot
Daily valuation snapshot
Clearmind Medicine Inc. Common Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $6.58
- Market capitalization (USD)
- $3,338,718.32
- Price / earnings (TTM)
- Not reported
- Price / book
- 2.8
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CMND in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CMND in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing CMND with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $6.58 |
| Market capitalization (USD) | $3,338,718.32 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.8 |
No matching rows. Clear the filter to see all records.
Read CMND's valuation metrics
Company size
Clearmind Medicine Inc. Common Shares's recorded market capitalization is $3,338,718.32. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
CMND's recorded price-to-book ratio is 2.8. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Clearmind Medicine Inc. Common Shares with Aurora
Use the snapshot above to ask a specific question about CMND. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow CMND's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.